Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.8 USD | +1.90% | +2.25% | +54.86% |
03:22pm | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
10/05 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.86% | 75.32M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Sector Update: Healthcare Stocks Posting Small Declines in Late Trade